KROS

NASDAQStock

Keros Therapeutics, Inc.

$10.93-0.06 (-0.55%)

52-Week Range

$9.55

$21.84

Key Stats

Market Cap

406.8M

P/E Ratio

7.01

Dividend Yield

—

Beta

0.90

Volume

368.8K

Avg Volume

496.5K

Performance

-33.72%

-48.23%

-30.44%

YTD

-40.72%

-5.42%

-74.80%

-81.85%

Price Chart

ETF Exposure

KROS is held by 74 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
DCOR	Dimensional - US Core Equity 1 ETF	0.00%	939	$10K	$2.68B	0.14%
DFAC	Dimensional - US Core Equity 2 ETF	0.00%	16,199	$178K	$40.55B	0.17%
DFAU	Dimensional - US Core Equity Market ETF	0.00%	2,492	$27K	$10.37B	0.12%
DFUS	Dimensional - US Equity Market ETF	0.00%	1,693	$19K	$18.51B	0.09%
DXUV	Dimensional - US Vector Equity ETF	0.00%	134	$1K	$351.7M	0.28%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	2	$27	$60.6M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	8	$90	$80.3M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	14	$154	$80.4M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	16	$177	$63.0M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	19	$210	$57.9M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	16	$175	$42.1M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	10	$115	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	8	$87	$21.0M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	3	$38	$9.3M	0.12%
IWV	iShares Russell 3000 ETF	0.00%	6,999	$79K	$17.30B	0.20%
LSLT	Pacer Salt Low truBeta US Market ETF	0.00%	394	$7K	$6.8M	0.60%
SCHB	Schwab U.S. Broad Market ETF	0.00%	11,035	$122K	$37.50B	0.03%
SLT	Pacer Salt High truBeta US Market ETF	0.00%	394	$7K	$6.3M	0.60%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.00%	394	$7K	$1.0M	0.79%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	29	$710	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	1,045	$25K	$12.17B	0.24%
VETS	Pacer Military Times Best Employers ETF	0.00%	394	$7K	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.00%	394	$7K	$3.7M	0.70%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	5	$122	$337.7M	0.32%

PreviousPage 2 of 2

About KROS ETF Exposure

Keros Therapeutics, Inc. (KROS) is held by 74 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 406.8M, KROS is a widely held institutional stock. The stock currently trades at $10.93. Investors can gain exposure to KROS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold KROS, sorted by portfolio weight.